Regency Capital Management Inc.\De Charles River Laboratories International, Inc. Transaction History

Regency Capital Management Inc.\De

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$203.52 - $273.43 $460,972 - $619,318	2,265 Added 14.46%	17,930 $4.86 Million
Q4 2023 Jan 23, 2024	BUY	$164.52 - $238.84 $2.58 Million - $3.74 Million	15,665 New	15,665 $3.7 Million
Q1 2022 May 05, 2022	SELL	$255.51 - $362.11 $203,385 - $288,239	-796 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$351.38 - $448.68 $395,653 - $505,213	-1,126 Reduced 58.58%	796 $300,000
Q3 2021 Nov 09, 2021	SELL	$372.64 - $458.3 $1.46 Million - $1.79 Million	-3,914 Reduced 67.07%	1,922 $793,000
Q2 2021 Jul 07, 2021	BUY	$294.17 - $371.65 $205,919 - $260,154	700 Added 13.63%	5,836 $2.16 Million
Q1 2021 May 25, 2021	BUY	$249.67 - $299.48 $1.28 Million - $1.54 Million	5,136 New	5,136 $1.49 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Regency Capital Management Inc.\De, based on Form 13F filings with the SEC.

Stay updated on Regency Capital Management Inc.\De with notifications on news.